Provided by Tiger Trade Technology Pte. Ltd.

Apogee Therapeutics

135.07
-0.0100-0.01%
Volume:563.33K
Turnover:76.09M
Market Cap:10.18B
PE:-31.12
High:135.08
Open:135.01
Low:135.01
Close:135.08
52wk High:135.08
52wk Low:35.39
Shares:75.34M
Float Shares:58.14M
Volume Ratio:1.44
T/O Rate:0.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3400
EPS(LYR):-4.2155
ROE:-32.46%
ROA:-20.30%
PB:8.52
PE(LYR):-32.04

Loading ...

Aug 11, 2026

Major Issues Report

Form 8-K - Current report
Aug 10, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2026

Major Issues Report

Form 8-K - Current report
Jul 08, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 08, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 08, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 22, 2026

Major Issues Report

Form 8-K - Current report
Jun 22, 2026

Major Issues Report

Form 8-K - Current report
Jun 12, 2026

Major Issues Report

Form 8-K - Current report
May 27, 2026

Major Issues Report

Form 8-K - Current report
May 27, 2026

Major Issues Report

Form 8-K - Current report
May 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 11, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 24, 2026

Major Issues Report

Form 8-K - Current report